The Brazilian Health Regulatory Agency's (ANVISA) inspection was conducted at Caplin Point Labs' Chennai facility between 12 and 16 August 2024 and concluded with zero observations.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.